Director

Sally E. Blount, Ph.D.

Director·Abbott Laboratories

About

Dr. Sally E. Blount has served as Chief Executive Officer of Catholic Charities of the Archdiocese of Chicago since 2020 and as the Michael L. Nemmers Professor of Strategy at the J.L. Kellogg Graduate School of Management at Northwestern University since 2010.

She served as Dean of the Kellogg School from 2010 to 2018 and joined Abbott's Board of Directors in 2011.

Since 2011
Age 64
Tenure 15 yrs

Also at Abbott Laboratories

NM Nita Ahuja, M.D. Director RM Robert J. Alpern, M.D. Director CB Claire Babineaux-Fontenot Director RF Robert B. Ford Chairman of the Board and Chief Executive Officer; Director PG Paola Gonzalez Director MK Michelle A. Kumbier Director

Roles

Organization Role Dates Details
Abbott Laboratories Director 2011–present Current role
Northwestern University, J.L. Kellogg Graduate School of Management Dean 2010 to 2018
New York University Dean of the Undergraduate College and Vice Dean of the Leonard N. Stern School of Business 2004 to 2010
New York University Leonard N. Stern School of Business Professor 2001 to 2010 Became the Abraham L. Gitlow Professor of Management in 2004.
University of Chicago Graduate School of Business Academic posts 1992 to 2001

External roles

Organization Role Dates
Ulta Beauty, Inc. Board of Directors member 2017 to 2022

Related

Company Abbott Laboratories Company hub Person Nita Ahuja, M.D. Director Person Robert J. Alpern, M.D. Director Person Claire Babineaux-Fontenot Director Person Robert B. Ford Chairman of the Board and Chief Executive Officer; Director Person Paola Gonzalez Director Person Michelle A. Kumbier Director Person Darren W. McDew Director Person Nancy McKinstry Lead Independent Director Person Michael G. O'Grady Director Person Michael F. Roman Director Person Daniel J. Starks Director Person John G. Stratton Director Deal Abbott Laboratories Advanced Medical Optics 2009 Deal page Deal Abbott Laboratories Alere 2017 Deal page Deal Abbott Laboratories Basf S Pharmaceutical Business Knoll 2001 Deal page
Source: Abbott Laboratories proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo